| 000 | 01781 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514000450.0 | ||
| 264 | 0 | _c20010906 | |
| 008 | 200109s 0 0 eng d | ||
| 022 | _a0264-410X | ||
| 024 | 7 |
_a10.1016/s0264-410x(01)00070-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKowalczyk, D W | |
| 245 | 0 | 0 |
_aVaccine regimen for prevention of sexually transmitted infections with human papillomavirus type 16. _h[electronic resource] |
| 260 |
_bVaccine _cMay 2001 |
||
| 300 |
_a3583-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdministration, Intranasal |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Viral _xbiosynthesis |
| 650 | 0 | 4 |
_aAntigens, Viral _xchemistry |
| 650 | 0 | 4 | _aCOS Cells |
| 650 | 0 | 4 | _aCapsid Proteins |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aEpitopes _xchemistry |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization, Secondary |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMicroscopy, Electron |
| 650 | 0 | 4 |
_aOncogene Proteins, Viral _xgenetics |
| 650 | 0 | 4 |
_aPapillomaviridae _xgenetics |
| 650 | 0 | 4 |
_aPapillomavirus Infections _ximmunology |
| 650 | 0 | 4 | _aPapillomavirus Vaccines |
| 650 | 0 | 4 |
_aTumor Virus Infections _ximmunology |
| 650 | 0 | 4 |
_aVaccines, DNA _xadministration & dosage |
| 650 | 0 | 4 |
_aVaccines, Synthetic _xadministration & dosage |
| 650 | 0 | 4 |
_aViral Vaccines _xadministration & dosage |
| 700 | 1 | _aWlazlo, A P | |
| 700 | 1 | _aShane, S | |
| 700 | 1 | _aErtl, H C | |
| 773 | 0 |
_tVaccine _gvol. 19 _gno. 25-26 _gp. 3583-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0264-410x(01)00070-6 _zAvailable from publisher's website |
| 999 |
_c11281373 _d11281373 |
||